These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2235951)
1. [Tisamide in the complex treatment of tuberculosis]. Onishchenko VV; Sokolova GB; Koriakin VA; Shapatava MN; Iurchenko LN Probl Tuberk; 1990; (7):43-5. PubMed ID: 2235951 [TBL] [Abstract][Full Text] [Related]
2. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
3. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
5. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
6. [The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs]. Roslik SM; Pashkov IuN; Gerasimova TG; Marveeva SL Probl Tuberk; 1990; (5):75-6. PubMed ID: 2388900 [No Abstract] [Full Text] [Related]
7. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide]. Schaberg T; Lode H Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286 [TBL] [Abstract][Full Text] [Related]
9. [Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid]. Kalankhodzhaev AA; Gamzaeva NF Probl Tuberk; 1991; (5):21-2. PubMed ID: 1924235 [TBL] [Abstract][Full Text] [Related]
10. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE; Zierski M; Graczyk J; Bek E; Farer LS Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [TBL] [Abstract][Full Text] [Related]
11. [Long-term results of short-course chemotherapy in pulmonary tuberculosis (final report). The third study: comparative study of two regimens, 6RHZ and -6RHS (treatment was continued for 6 months after negative conversion of sputum by culture)]. Baba H; Shinkai A; Izuchi R; Azuma Y Kekkaku; 1988 Apr; 63(4):239-46. PubMed ID: 3136270 [No Abstract] [Full Text] [Related]
12. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
13. [Short-term chemotherapy of tuberculosis. Cooperative French trial]. Pretet S Rev Fr Mal Respir; 1983; 11(6):859-66. PubMed ID: 6366945 [TBL] [Abstract][Full Text] [Related]
15. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]. Pretet S; Grosset J; Perdrizet S Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140 [No Abstract] [Full Text] [Related]
16. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
17. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels. Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis]. Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511 [TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis]. Kawakami K Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs]. Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]